This study sought to evaluate, in HOCM patients, the utility of NT-proBNP and cTnI, as well as CK-MB, hs-CRP, and big ET-1 to predict myocardial fibrosis as assessed noninvasively by LGE with CMR. The gene discussed is NPPB; the disease is Myocardial fibrosis.